---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-080583"
form_type: "8-K"
ticker: null
cik: "0000786947"
company_name: "ACURA PHARMACEUTICALS, INC"
filed_at: "2023-07-13T23:59:59+00:00"
generated_at: "2026-06-13T09:11:58.594763+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Acura Pharma gets $200K related-party loan, warns it may run out of funds by mid-August

## Summary
- Received $200,000 loan from AD Pharma (66% owner), total principal now $3,669,279.
- Loan bears interest at 5.25%, matures Dec 31, 2023; default rate 7.5%.
- Proceeds fund operations only through mid-August 2023.
- Without additional financing, company may scale back/terminate operations or seek bankruptcy.
- AD Pharma is controlled by Mr. Schutte, who directly owns ~14% of Acura stock.

## SEC filing metadata
- accession: 0001104659-23-080583
- form_type: 8-K
- cik: 0000786947
- company_name: ACURA PHARMACEUTICALS, INC
- filed_at: 2023-07-13T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 2.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/786947/000110465923080583/0001104659-23-080583-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/786947/000110465923080583/tm2321204d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-080583
- JSON: https://secwatch.observer/filing/0001104659-23-080583.json
- Plain text: https://secwatch.observer/filing/0001104659-23-080583.txt

## Key facts
- Debt Financings
  ACURA PHARMACEUTICALS, INC incurred loan of $200,000 with Abuse Deterrent Pharma, LLC at 5.25% maturing December 31, 2023.
  - Instrument: loan
  - Principal: $200,000
  - Counterparty: Abuse Deterrent Pharma, LLC
  - Rate: 5.25%
  - Maturity: December 31, 2023
  - Event: incurrence
  source text: On July 10, 2023 we received a $200,000 loan from Abuse Deterrent Pharma, LLC ("AD Pharma"). This loan combined with previous loans made to the Company and with the $2,319,279 under the November 10, 2022 Amended Consolidated and Restated Secured Promissory Note, now totals $3,669,279, bears interest at 5.25% and matures on December 31, 2023, at which time all principal and interest is due.
  evidence_url: https://www.sec.gov/Archives/edgar/data/786947/000110465923080583/0001104659-23-080583-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.